Related references
Note: Only part of the references are listed.Safety, Tolerability, and Pharmacokinetics of MEDI8897, the Respiratory Syncytial Virus Prefusion F-Targeting Monoclonal Antibody with an Extended Half-Life, in Healthy Adults
M. Pamela Griffin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera
Joan O. Ngwuta et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Modeling maternal fetal RSV F vaccine induced antibody transfer in guinea pigs
Gregory M. Glenn et al.
VACCINE (2015)
Characterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion Glycoprotein
Morgan S. A. Gilman et al.
PLOS PATHOGENS (2015)
Structural Delineation of a Quaternary, Cleavage-Dependent Epitope at the gp41-gp120 Interface on Intact HIV-1 Env Trimers
Claudia Blattner et al.
IMMUNITY (2014)
Glycan variants of a respiratory syncytial virus antibody with enhanced effector function and in vivo efficacy
Andrew Hiatt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
How good are my data and what is the resolution?
Philip R. Evans et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2013)
A Novel Investigational Fc-Modified Humanized Monoclonal Antibody, Motavizumab-YTE, Has an Extended Half-Life in Healthy Adults
Gabriel J. Robbie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Cross-neutralization of four paramyxoviruses by a human monoclonal antibody
Davide Corti et al.
NATURE (2013)
Respiratory Syncytial Virus-Associated Hospitalizations Among Children Less Than 24 Months of Age
Caroline Breese et al.
PEDIATRICS (2013)
Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody
Jason S. McLellan et al.
SCIENCE (2013)
Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
Jason S. McLellan et al.
SCIENCE (2013)
Collaboration gets the most out of software
Andrew Morin et al.
ELIFE (2013)
Population Pharmacokinetics of Palivizumab, a Humanized Anti-Respiratory Syncytial Virus Monoclonal Antibody, in Adults and Children
Gabriel J. Robbie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Hospitalizations Associated With Influenza and Respiratory Syncytial Virus in the United States, 1993-2008
Hong Zhou et al.
CLINICAL INFECTIOUS DISEASES (2012)
Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention
Margarita Magro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Paramyxovirus Fusion and Entry: Multiple Paths to a Common End
Andres Chang et al.
VIRUSES-BASEL (2012)
iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM
T. Geoff G. Battye et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2011)
Analysis of Respiratory Syncytial Virus Preclinical and Clinical Variants Resistant to Neutralization by Monoclonal Antibodies Palivizumab and/or Motavizumab
Qing Zhu et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis
Harish Nair et al.
LANCET (2010)
Generation of stable monoclonal antibody-producing B cell receptor-positive human memory B cells by genetic programming
Mark J. Kwakkenbos et al.
NATURE MEDICINE (2010)
Exploring the Association between Severe Respiratory Syncytial Virus Infection and Asthma A Registry-based Twin Study
Simon Francis Thomsen et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
The severity-dependent relationship of infant bronchiolitis on the risk and morbidity of early childhood asthma
Kecia N. Carroll et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Preclinical development of monoclonal antibodies Considerations for the use of non-human primates
Kathryn Chapman et al.
MABS (2009)
The Burden of Respiratory Syncytial Virus Infection in Young Children
Caroline Breese Hall et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Modelling the human immune response: performance of a 1011 human antibody repertoire against a broad panel of therapeutically relevant antigens
C. Lloyd et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2009)
Codon stabilization analysis of the 248 temperature sensitive mutation for increased phenotypic stability of respiratory syncytial virus vaccine candidates
Cindy Luongo et al.
VACCINE (2009)
Increasing burden and risk factors for bronchiolitis-related medical visits in infants enrolled in a state health care insurance plan
Kecia N. Carroll et al.
PEDIATRICS (2008)
Development of a PIV-vectored RSV vaccine: Preclinical evaluation of safety, toxicity, and enhanced disease and initial clinical testing in healthy adults
Roderick S. Tang et al.
VACCINE (2008)
The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines
Peter F. Wright et al.
VACCINE (2007)
The association between respiratory syncytial virus infection and the development of childhood asthma -: A systematic review of the literature
Eduardo G. Perez-Yarza et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2007)
Phaser crystallographic software
Airlie J. McCoy et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2007)
Live attenuated versus inactivated influenza vaccine in infants and young children
Robert B. Belshe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor (FcRn)
William F. Dall'Acqua et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Isolation and characterization of monoclonal antibodies which neutralize human Metapneumovirus in vitro and in vivo
Nancy D. Ulbrandt et al.
JOURNAL OF VIROLOGY (2006)
Ultra-potent antibodies against respiratory syncytial virus: Effects of binding kinetics and binding valence on viral neutralization
H Wu et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Effects of viral respiratory infections on lung development and childhood asthma
JE Gern et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)
Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13
N Sigurs et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Coot:: model-building tools for molecular graphics
P Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease
TF Feltes et al.
JOURNAL OF PEDIATRICS (2003)
Increasing the affinity of a human IgG1, for the neonatal Fc receptor: Biological consequences
WF Dall'Acqua et al.
JOURNAL OF IMMUNOLOGY (2002)
PHENIX:: building new software for automated crystallographic structure determination
PD Adams et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2002)
A neutralizing antibody Fab-influenza haemagglutinin complex with an unprecedented 2:1 stoichiometry:: characterization and crystallization
B Gigant et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2000)
Share Paper
